SFPG
ABBV icon

Stonebridge Financial Planning Group’s AbbVie ABBV Stock Holding History

Stonebridge Financial Planning Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-150
Closed -$21K – 111
2021
Q4 		$21K Hold
150
– – 0.01% 294
2021
Q3 		$18K Hold
150
– – 0.01% 302
2021
Q2 		$18K Sell
150
-50
-25% -$5.63K 0.01% 305
2021
Q1 		$22K Sell
200
-25
-11% -$2.67K 0.01% 294
2020
Q4 		$24K Hold
225
– – 0.02% 258
2020
Q3 		$19K Hold
225
– – 0.01% 267
2020
Q2 		$22K Hold
225
– – 0.02% 253
2020
Q1 		$18K Buy
225
+75
+50% +$6.39K 0.02% 253
2019
Q4 		$13K Buy
+150
New +$12.5K 0.01% 269

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Stonebridge Financial Planning Group's ABBV Position: Q1 2022 in Review

Stonebridge Financial Planning Group sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 150 shares — an estimated $21K sold.

Stonebridge Financial Planning Group first reported a position in ABBV in Q4 2019 and held it in 9 quarters. The position peaked at $24K in Q4 2020. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

  • Stonebridge Financial Planning Group reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
  • Stonebridge Financial Planning Group sold 150 AbbVie shares in Q1 2022, an estimated $21K.
  • Stonebridge Financial Planning Group first reported a position in AbbVie in Q4 2019 and held it in 9 quarters.
  • Stonebridge Financial Planning Group's AbbVie position peaked at $24K in Q4 2020.
  • 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Stonebridge Financial Planning Group's 13F filing for Q1 2022, filed 10 May 2022.